Impact of GABA pathway genes expression on first-line treatment outcomes in metastatic colorectal cancer (mCRC) patients: data from the CALGB/SWOG 80405 trial (Alliance).
- Citation:
- J Clin Oncol vol 24 (13 Supplement) 3588
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Pfizer, Genentech
- Grants:
- U10CA180821, U10CA180882, U10CA180820 and UG1CA233277 (ECOG-ACRIN); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Francesca Battaglin Yan Yang Joshua Millstein Shivani Soni Sandra Algaze Karam Ashouri Pooja Mittal Priya Jayachandran Alexandra Wong Jae-Ho Lo Lesly Torres-Gonzalez Wu Zhang Fang-Shu Ou Alan P Venook Federico Innocenti Shannon M Mumenthaler Heinz-Josef Lenz
- Networks:
- CA011, CA136, LAPS-MN026, LAPS-NC007
- Study
- Alliance-A152001
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: